VANI Vivani Medical, Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 13, 2026
$1,23
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,9252 haftanın en düşüğü
$1,9252 haftanın en yükseği
Piyasa Değeri (MRQ)
$110M
P/E
-3.2
Hisse Başına Kâr
$-0.43
Gelir
$0
rozetleriniz
52 Haftlık Aralık
$1–$2
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$4
P/E
-3.2
ROE
-257.8%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
VANI Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.23
Piyasa Değeri (MRQ)
$110M
P/E
-3.2
Hisse Başına Kâr
$-0.43
Gelir
$0
ROE
-257.8%
52 Haftlık Aralık
$1–$2
VANI Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 19 Ağustos 2022 | 1-for-3 | Ters |
| 06 Ocak 2020 | 1-for-8 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$02016-12-31 → 2025-12-31
Hisse Başına Kâr$-0.432023-12-31 → 2025-12-31
Serbest Nakit Akışı$-25M2016-12-31 → 2025-12-31
Net kar marjı·2016-12-31 → 2018-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | VANI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -3.25Y ort. ≈-2.5 | ≈-2.5 | · | · | |
| F/D (MRQ) | 5.85Y ort. ≈2.7 | ≈2.7 | 4.0 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -4.15Y ort. ≈-2.3 | ≈-2.3 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -4.35Y ort. ≈-2.4 | ≈-2.4 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 6.65Y ort. ≈2.2 | ≈2.2 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | VANI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -65.7%5Y ort. ≈-55.4% | ≈-55.4% | -57.2% | Zayıf | |
| ROE | -257.8%5Y ort. ≈-131.7% | ≈-131.7% | -41.5% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | VANI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 3.25Y ort. ≈4.3 | ≈4.3 | 4.5 | Ortalamanın altında | |
| Quick Ratio (Cari Oran) | 2.55Y ort. ≈3.0 | ≈3.0 | 4.1 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | VANI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.0 | · | 0.1 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$0.00 | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
2.1%
Sonraki Rapor
Kas 11, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 18, 2026 | $-0.07 | $-0.09 | 17.6% |
| 31 Mart 2026 | May 18, 2026 | $-0.08 | $-0.08 | 2.0% |
| 31 Aralık 2025 | $-0.09 | $-0.10 | 11.8% | |
| 30 Eylül 2025 | $-0.11 | $-0.11 | 2.0% | |
| 30 Haziran 2025 | $-0.12 | $-0.10 | -17.6% | |
| 31 Mart 2025 | $-0.11 | $-0.11 | -2.7% | |
| 31 Aralık 2024 | $-0.11 | $-0.11 | 2.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | · | · | · | · | $3M | $7M | $8M | $4M | $9M | $3M | |
| Cost of Revenue | · | · | · | · | $130.0K | $500.0K | $2M | $5M | $5M | $10M | $5M | $4M | |
| Gross Profit | · | · | · | · | $130.0K | $500.0K | $1M | $2M | $3M | $-6M | $4M | $-160.0K | |
| R&D Expense | $18M | $16M | $17M | $14M | $11M | $5M | $13M | $10M | $8M | $5M | $3M | $5M | |
| SG&A Expense | $9M | $9M | $10M | $7M | $2M | $6M | $9M | $11M | $11M | $10M | $8M | $7M | |
| Operating Expenses | $28M | $25M | $27M | $21M | $13M | $15M | $35M | $37M | $31M | $27M | $24M | $21M | |
| Operating Income | $-28M | $-25M | $-27M | $-21M | $-13M | $-15M | $-34M | $-35M | $-29M | $-33M | $-20M | $-21M | |
| Interest Income | · | · | · | $475.0K | $550.0K | $16.0K | $362.0K | $86.0K | $93.0K | $31.0K | $2.0K | $9.0K | |
| Other Non-op | $947.0K | $1M | $1M | · | · | · | · | · | · | · | $27.0K | $12.0K | |
| Pretax Income | $-27M | $-23M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | · | $2.0K | · | · | · | · | $0 | $0 | · | · | · | · | |
| Net Income | $-27M | $-23M | $-26M | $-14M | $-13M | $-15M | $-34M | $-35M | $-29M | $-33M | $-20M | $-35M | |
| EPS (Basic) | $-0.43 | $-0.43 | $-0.50 | · | · | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.43 | $-0.43 | $-0.50 | · | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 62,389,000 | 54,981,000 | 50,853 | · | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 62,389,000 | 54,981,000 | 50,853 | · | · | · | · | · | · | · | · | · | |
| EBITDA | $-27M | $-24M | $-27M | $-21M | · | · | · | $-35M | $-28M | $-33M | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $18M | $21M | $45M | $2M | $2M | $11M | $4M | $8M | $11M | $16M | $619.0K | |
| Receivables | · | · | · | · | · | · | $455.0K | $504.0K | $2M | $274.0K | $2M | $708.0K | |
| Inventory | · | · | · | · | · | · | $1M | $3M | $3M | $3M | $8M | $6M | |
| Prepaid Expense | $1M | $2M | $2M | $2M | $291.0K | $1M | $299.0K | $1M | $795.0K | $717.0K | $1M | $927.0K | |
| Current Assets | $18M | $20M | $23M | $48M | $2M | $4M | $13M | $10M | $13M | $15M | $27M | $42M | |
| PP&E (Net) | $3M | $2M | $2M | $1M | $1M | $174.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $6M | $4M | $4M | $4M | $3M | $653.0K | $5M | $4M | $4M | $4M | $6M | $5M | |
| Accum. Depreciation | $3M | $3M | $2M | $2M | $2M | $479.0K | $4M | $3M | $3M | $2M | $5M | $4M | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | |
| Total Assets | $39M | $42M | $46M | $51M | $5M | $4M | $17M | $11M | $14M | $17M | $28M | $43M | |
| Accounts Payable | $1M | $817.0K | $542.0K | $1M | $281.0K | $486.0K | $1M | $1M | $752.0K | $1M | $710.0K | $513.0K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $895.0K | $1M | $2M | $3M | $2M | $2M | $2M | $1M | |
| Current Liabilities | $7M | $6M | $6M | $7M | $2M | $5M | $7M | $8M | $7M | $6M | $8M | $8M | |
| Capital Leases | $17M | $18M | $19M | · | $902.0K | · | $2M | · | · | · | · | · | |
| Total Liabilities | $24M | $24M | $25M | $7M | $3M | $5M | $9M | $8M | · | · | · | · | |
| Common Stock | $8.0K | $6.0K | $5.0K | $5.0K | $55M | $270M | $264M | $229M | $202M | $187M | $166M | $163M | |
| Paid-in Capital | $164M | $139M | $119M | $117M | $7M | $49M | $49M | $44M | $41M | $31M | $27M | $25M | |
| Retained Earnings | $-149M | $-122M | $-98M | $-73M | $-59M | $-320M | $-305M | $-269M | $-234M | $-206M | $-173M | $-153M | |
| AOCI | $30.0K | $48.0K | $140.0K | $35.0K | · | $-448.0K | $-562.0K | $-575.0K | $-572.0K | $-608.0K | $-581.0K | $-474.0K | |
| Stockholders' Equity | $16M | $18M | $21M | $44M | $2M | $2M | $7M | $3M | $8M | $11M | $20M | $35M | |
| Liabilities + Equity | $39M | $42M | $46M | $51M | $5M | $4M | $17M | $11M | $14M | $17M | $28M | $43M | |
| Shares Outstanding | 76,428,000 | 59,235,000 | 51,031,000 | 50,736,000 | 36,803 | 32,197 | 15,643 | 9,542,000 | 7,204 | 42,701,000 | 35,942,000 | 35,241,000 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $424.0K | $400.0K | $357.0K | $381.0K | $345.0K | $164.0K | $397.0K | $435.0K | $457.0K | $432.0K | $335.0K | $279.0K | |
| Stock-based Comp | $1M | $2M | $2M | $1M | $2M | $421.0K | $3M | $4M | $4M | $3M | $3M | $1M | |
| Restructuring | · | · | · | · | · | $2M | $3M | $555.0K | · | · | · | · | |
| Other Non-cash | $381.0K | $690.0K | $-268.0K | $-7M | · | · | · | $1M | $328.0K | $4M | · | · | |
| Operating Cash Flow | $-24M | $-21M | $-24M | $-19M | $-11M | $-17M | $-28M | $-30M | $-24M | $-25M | $-21M | $-17M | |
| CapEx | $1M | $556.0K | $887.0K | $338.0K | $572.0K | $330.0K | $493.0K | $163.0K | $265.0K | $490.0K | $762.0K | $560.0K | |
| Investing Cash Flow | $-1M | $-556.0K | $-887.0K | $-338.0K | $-572.0K | $68.0K | $-493.0K | $-163.0K | $-265.0K | $-490.0K | $18M | $-26M | |
| Stock Issued | · | · | · | · | · | · | · | $26M | $21M | $19M | · | $43M | |
| Net Stock Activity | · | · | · | · | · | · | · | $26M | · | · | · | · | |
| Financing Cash Flow | $23M | $19M | $133.0K | $63M | $12M | $9M | $35M | $27M | $21M | $20M | $3M | $44M | |
| Net Change in Cash | $-2M | $-2M | $-24M | $44M | $97.0K | $-8M | $7M | $-3M | $-3M | $-5M | $-380.0K | $557.0K | |
| Taxes Paid | · | $2.0K | $1.0K | · | $1.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | $-25M | $-21M | $-25M | $-19M | · | · | · | $-30M | $-24M | $-26M | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 29.1% | 35.8% | -152.3% | · | · | |
| Operating Margin | · | · | · | · | · | · | · | -510.1% | -359.2% | -830.2% | · | · | |
| Net Margin | · | · | · | · | · | · | · | -508.9% | -358.1% | -829.5% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | -503.8% | -353.5% | -819.4% | · | · | |
| ROA | -65.7% | -53.8% | -52.9% | -49.1% | · | · | · | -278.8% | -182.2% | -147.3% | · | · | |
| ROE | -257.8% | -130.7% | -109.2% | -29.0% | · | · | · | -1006.1% | -273.5% | -209.0% | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 3.4 | 4.0 | 7.0 | · | · | · | 1.3 | 2.0 | 2.7 | · | · | |
| Quick Ratio | 2.5 | 3.1 | 3.6 | · | · | · | · | 0.7 | 0.4 | 0.1 | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | 0.5 | 0.5 | 0.2 | · | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 1.6 | 1.7 | 1.7 | · | · | |
| Receivables Turnover | · | · | · | · | · | · | · | 5.9 | 7.6 | 4.5 | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.21 | $0.30 | $406.83 | $0.87 | · | · | · | $0.04 | $0.14 | $261.07 | · | · | |
| Revenue / Share | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.39 | $-378.06 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.21 | $0.31 | $404.73 | · | · | · | · | $0.06 | $0.01 | $12.62 | · | · | |
| EPS (TTM) | $-0.43 | $-0.43 | $-0.50 | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $7M | $8M | $4M | $9M | $3M | |
| Net Income TTM | $-27M | $-23M | $-26M | $-14M | $-13M | $-15M | $-34M | $-35M | $-29M | $-33M | $-20M | $-35M | |
| Market Cap | $94M | $69M | $52.1K | $43M | · | · | · | $1.62B | $2.64B | $2M | · | · | |
| P/E | -2.9 | -2.7 | -2.0 | · | · | · | · | · | · | · | · | · | |
| P/S | · | · | 0.0 | 12.8 | · | · | · | 235.2 | 331.7 | 0.5 | · | · | |
| P/B | 6.0 | 3.9 | 0.0 | 1.0 | · | · | · | 526.3 | 335.2 | 0.2 | · | · | |
| P / Tangible Book | 6.0 | 3.9 | 0.0 | 1.0 | 0.1 | 66.8 | · | · | · | · | · | · | |
| P / Cash Flow | -3.9 | -3.3 | -0.0 | -2.3 | · | · | · | -54.5 | -110.3 | -0.1 | · | · | |
| P / FCF | -3.7 | -3.2 | -0.0 | -2.3 | · | · | · | -54.2 | -109.1 | -0.1 | · | · | |
| Earnings Yield | -35.0% | -37.1% | -49.0% | · | · | · | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $0 | $0 | · | $0 | · | · | · | · | · | · | · | · | |
| R&D Expense | $4M | $4M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | $2M | |
| Operating Expenses | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | $5M | |
| Operating Income | $-7M | $-7M | $-7M | $-7M | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M | $-6M | $-7M | $-7M | $-7M | $-8M | $-5M | |
| Other Non-op | $504.0K | $-167.0K | $2M | $-195.0K | $-318.0K | $-255.0K | $2M | $-262.0K | $-311.0K | $-188.0K | · | · | · | · | · | · | |
| Net Income | $-6M | $-7M | $-7M | $-7M | $-7M | $-6M | $-6M | $-6M | $-5M | $-6M | $-6M | $-7M | $-7M | $-6M | $-7M | $1M | |
| EPS (Basic) | $-0.07 | $-0.08 | $-0.09 | $-0.11 | $-0.12 | $-0.11 | $-0.10 | $-0.11 | $-0.10 | $-0.12 | $-0.36 | $-0.13 | $-0.13 | $0.12 | · | $0.04 | |
| EPS (Diluted) | $-0.07 | $-0.08 | $-0.09 | $-0.11 | $-0.12 | $-0.11 | $-0.10 | $-0.11 | $-0.10 | $-0.12 | $-0.11 | $-0.13 | $-0.13 | · | · | $0.04 | |
| Shares (Basic) | 87,090,000 | 81,269,000 | · | 59,711,000 | 59,244,000 | 59,236,000 | · | 55,247,000 | 55,021,000 | 52,202,000 | · | 50,837,000 | 50,795,000 | 50,755,000 | · | 37,965 | |
| Shares (Diluted) | 87,090,000 | 81,269,000 | · | 59,711,000 | 59,244,000 | 59,236,000 | · | 55,247,000 | 55,021,000 | 52,202,000 | · | 50,837,000 | 50,795,000 | 50,755 | · | 38,477 | |
| EBITDA | $-7M | $-7M | · | $-7M | $-7M | $-6M | · | $-6M | $-6M | $-6M | · | $-7M | $-7M | $-6M | · | $-5M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $20M | $16M | $3M | $7M | $13M | $18M | $20M | $25M | $30M | $21M | $25M | $32M | $38M | $45M | $52M | |
| Receivables | · | $12.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $1M | $1M | $883.0K | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $6M | $4M | $3M | $2M | $3M | |
| Current Assets | $22M | $22M | $18M | $4M | $9M | $15M | $20M | $21M | $26M | $32M | $23M | $31M | $36M | $41M | $48M | $54M | |
| PP&E (Net) | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $4M | $4M | $6M | $6M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Accum. Depreciation | $1M | $1M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-current Assets | $892.0K | $1M | · | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | $1M | $1M | $1M | · | |
| Total Assets | $42M | $42M | $39M | $25M | $29M | $35M | $42M | $43M | $48M | $54M | $46M | $53M | $60M | $45M | $51M | $57M | |
| Accounts Payable | $1M | $1M | $1M | $1M | $2M | $1M | $817.0K | $815.0K | $645.0K | $570.0K | $542.0K | $2M | $2M | $746.0K | $1M | $2M | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $7M | $7M | $6M | $7M | $6M | |
| Capital Leases | $16M | $16M | $17M | $17M | $17M | $18M | $18M | $18M | $19M | $19M | $19M | $20M | $20M | $349.0K | · | $42.0K | |
| Total Liabilities | $23M | $23M | $24M | $24M | $24M | $24M | $24M | $25M | $24M | $25M | $25M | $27M | $27M | $6M | $7M | $6M | |
| Common Stock | $9.0K | $8.0K | $8.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $109M | $5.0K | $109M | |
| Paid-in Capital | $181M | $174M | $164M | $143M | $140M | $140M | $139M | $134M | $134M | $133M | $119M | $119M | $118M | $8M | $117M | $8M | |
| Retained Earnings | $-162M | $-155M | $-149M | $-142M | $-135M | $-128M | $-122M | $-116M | $-110M | $-104M | $-98M | $-92M | $-86M | $-79M | $-73M | $-66M | |
| AOCI | $32.0K | $32.0K | $30.0K | $141.0K | $81.0K | $42.0K | $48.0K | $92.0K | $63.0K | $88.0K | $140.0K | $46.0K | $65.0K | $44.0K | $35.0K | $-26.0K | |
| Stockholders' Equity | $19M | $19M | $16M | $1M | $5M | $12M | $18M | $18M | $24M | $29M | $21M | $26M | $32M | $38M | $44M | $51M | |
| Liabilities + Equity | $42M | $42M | $39M | $25M | $29M | $35M | $42M | $43M | $48M | $54M | $46M | $53M | $60M | $45M | $51M | $57M | |
| Shares Outstanding | 89,410,000 | 84,648,000 | 76,428,000 | 61,511,000 | 59,244,000 | 59,244,000 | 59,235,000 | 55,266,000 | 55,197,000 | 54,978 | 51,031,000 | 51,025 | 50,799 | 50,789 | 50,736 | 50,736 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $130.0K | $115.0K | $105.0K | $102.0K | $102.0K | $89.0K | $112.0K | $100.0K | $99.0K | $98.0K | $71.0K | $80.0K | $108.0K | $110.0K | $240.0K | |
| Stock-based Comp | $313.0K | $312.0K | $467.0K | $276.0K | $391.0K | $350.0K | $402.0K | $472.0K | $383.0K | $353.0K | $460.0K | $511.0K | $524.0K | $369.0K | $171.0K | $1M | |
| Other Non-cash | · | $142.0K | · | · | · | $687.0K | · | · | · | $1M | · | · | · | $-1M | · | · | |
| Operating Cash Flow | $-6M | $-6M | $-7M | $-6M | $-6M | $-5M | $-6M | $-6M | $-5M | $-5M | $-3M | $-8M | $-6M | $-7M | $-5M | $-8M | |
| CapEx | $99.0K | $3.0K | $274.0K | $823.0K | $71.0K | $5.0K | $296.0K | $41.0K | $37.0K | $182.0K | $743.0K | $63.0K | $44.0K | $37.0K | $89.0K | $231.0K | |
| Investing Cash Flow | $-99.0K | $-3.0K | $-274.0K | $-823.0K | $-71.0K | $-5.0K | $-296.0K | $-41.0K | $-37.0K | $-182.0K | $-743.0K | $-63.0K | $-44.0K | $-37.0K | $-41.0K | $8M | |
| Financing Cash Flow | $6M | $10M | $21M | $3M | $-95.0K | $-170.0K | $5M | $427.0K | $109.0K | $14M | $23.0K | $103.0K | · | · | $0 | $55M | |
| Net Change in Cash | $-301.0K | $4M | $14M | $-4M | $-6M | $-5M | $-1M | $-5M | $-5M | $9M | $-4M | $-8M | $-6M | $-7M | $-5M | $63M | |
| Taxes Paid | · | · | · | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K | · | · | $0 | $1.0K | · | · | |
| Free Cash Flow | · | $-6M | · | · | · | $-5M | · | · | · | $-5M | · | · | · | $-7M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -18.1% | -17.4% | · | -19.2% | -18.5% | -14.1% | · | -12.6% | -9.9% | -12.3% | · | -12.3% | -10.4% | -11.2% | · | 2.2% | |
| ROE | -53.4% | -44.2% | · | -66.5% | -49.7% | -31.2% | · | -27.1% | -19.1% | -18.0% | · | -17.5% | -13.7% | -12.1% | · | 2.4% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.2 | · | 0.6 | 1.3 | 2.4 | · | 3.4 | 4.6 | 5.1 | · | 4.1 | 5.1 | 6.9 | · | 9.7 | |
| Quick Ratio | 3.0 | 2.9 | · | 0.4 | 1.0 | 2.1 | · | 3.1 | 4.3 | 4.8 | · | 3.3 | 4.6 | 6.5 | · | 9.2 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.21 | $0.23 | · | $0.02 | $0.08 | $0.20 | · | $0.33 | $0.43 | $522.21 | · | $513.61 | $637.69 | $755.44 | · | $1012.30 | |
| Revenue / Share | · | · | · | · | · | $0.00 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $-0.09 | · | · | · | · | · | · | · | $-137.25 | · | · | |
| Cash / Share | $0.22 | $0.23 | · | $0.04 | $0.11 | $0.22 | · | $0.36 | $0.45 | $539.27 | · | $486.45 | $639.50 | $749.63 | · | $1018.68 | |
| EPS (TTM) | $-0.35 | $-0.40 | · | $-0.44 | $-0.44 | $-0.42 | · | $-0.44 | $-0.46 | $-0.49 | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Net Income TTM | $-26M | $-27M | · | $-26M | $-26M | $-24M | · | $-23M | $-24M | $-25M | · | $-27M | $-19M | $-16M | · | $-10M | |
| Market Cap | $111M | $85M | · | $87M | $76M | $62M | · | $65M | $70M | $101.7K | · | $52.0K | $61.5K | $50.8K | · | $115.7K | |
| P/E | -3.5 | -2.5 | · | -3.2 | -2.9 | -2.5 | · | -2.7 | -2.7 | -3.8 | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | · | 20.6 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| P/B | 5.8 | 4.4 | · | 66.3 | 15.6 | 5.4 | · | 3.5 | 2.9 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| P / Tangible Book | 5.8 | 4.4 | · | 66.3 | 15.6 | 5.4 | · | 3.5 | 2.9 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| P / Cash Flow | · | -13.7 | · | · | · | -12.0 | · | · | · | -0.0 | · | · | · | -0.0 | · | · | |
| Earnings Yield | -28.2% | -40.0% | · | -31.2% | -34.1% | -40.0% | · | -37.6% | -36.5% | -26.5% | · | · | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $0 | $0 | · | · | · |
| Net Gelir | $-27M | $-23M | $-26M | $-14M | $-13M |
| Seyreltilmiş Hisse Başı Kâr | $-0.43 | $-0.43 | $-0.50 | · | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 2.7 | 3.4 | 4.0 | 7.0 | · |
| Cari Oran | 2.5 | 3.1 | 3.6 | · | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-25M | $-21M | $-25M | $-19M | · |
Kurumsal Sahipler (13F) 37 dosya · $8.0M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
37
Tutulan Değer
$8.0M
Yeni pozisyonlar
6
Çıkan pozisyonlar
13
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 6 (-8 önceki Ç'ye göre) | 13 (+9 önceki Ç'ye göre) | 7 (+1 önceki Ç'ye göre) | 12 (+3 önceki Ç'ye göre) | -406K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2.192.415 | 1.768.077 | 27,25% | Hisse senetleri |
| VANGUARD GROUP INC | $1.909.955 | 1.552.809 | 23,74% | Hisse senetleri |
| Tanager Wealth Management LLP | $753.022 | 607.276 | 9,36% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $728.911 | 587.745 | 9,06% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $509.518 | 410.902 | 6,33% | Hisse senetleri |
| COMMONWEALTH EQUITY SERVICES, LLC | $409.900 | 330.565 | 5,09% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $403.573 | 325.462 | 5,02% | Hisse senetleri |
| BlackRock, Inc. | $374.267 | 301.828 | 4,65% | Hisse senetleri |
| STATE STREET CORP | $192.157 | 154.965 | 2,39% | Hisse senetleri |
| NORTHERN TRUST CORP | $144.965 | 116.907 | 1,80% | Hisse senetleri |
| MAI Capital Management | $123.839 | 99.870 | 1,54% | Hisse senetleri |
| UBS Group AG | $63.374 | 51.108 | 0,79% | Hisse senetleri |
| ARMSTRONG ADVISORY GROUP, INC | $55.800 | 45.000 | 0,69% | Hisse senetleri |
| XTX Topco Ltd | $38.810 | 31.298 | 0,48% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $35.149 | 28.346 | 0,44% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $20.186 | 16.279 | 0,25% | Hisse senetleri |
| StoneX Group Inc. | $18.634 | 14.143 | 0,23% | Hisse senetleri |
| KESTRA PRIVATE WEALTH SERVICES, LLC | $15.148 | 12.216 | 0,19% | Hisse senetleri |
| Headlands Technologies LLC | $13.976 | 11.271 | 0,17% | Hisse senetleri |
| MARSHALL WACE, LLP | $13.839 | 11.161 | 0,17% | Hisse senetleri |
| LAZARI CAPITAL MANAGEMENT, INC. | $12.400 | 10.000 | 0,15% | Hisse senetleri |
| JPMORGAN CHASE & CO | $4.101 | 3.389 | 0,05% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $3.750 | 3.024 | 0,05% | Hisse senetleri |
| Steward Partners Investment Advisory, LLC | $2.480 | 2.000 | 0,03% | Hisse senetleri |
| SBI Securities Co., Ltd. | $1.443 | 1.164 | 0,02% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $1.440 | 1.200 | 0,02% | Hisse senetleri |
| BARCLAYS PLC | $822 | 663 | 0,01% | Hisse senetleri |
| Strategic Wealth Partners, Ltd. | $496 | 400 | 0,01% | Hisse senetleri |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $384 | 312 | 0,00% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $272 | 220 | 0,00% | Hisse senetleri |
| FMR LLC | $176 | 142 | 0,00% | Hisse senetleri |
| NFSG Corp | $128 | 103 | 0,00% | Hisse senetleri |
| GSA CAPITAL PARTNERS LLP | $75 | 60.866 | 0,00% | Hisse senetleri |
| HRT FINANCIAL LP | $17 | 13.947 | 0,00% | Hisse senetleri |
| MORGAN STANLEY | $12 | 10 | 0,00% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $7 | 6 | 0,00% | Hisse senetleri |
| DANSKE BANK A/S | $1 | 1 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Williams Gregg, Gregg G. Williams 2006 Trust, Sam Williams Family Investments LLC, Williams International Co. LLC, Sam B. Williams 1995 Generation Skipping Trust | 19 Mayıs 2026 | 47,10% | Değişiklik | Pasif yatırım | SEC |
| Gregg Williams, Gregg G. Williams 2006 Trust, Sam Williams Family Investments LLC, Williams International Co. LLC, Sam B. Williams 1995 Generation Skipping Trust ×11 başvurular | 02 Mayıs 2023 | · | İlk başvuru | Pasif yatırım | SEC |
| Joachim Bolck 2) | 25 Nisan 2023 | · | İlk başvuru | Pasif yatırım | SEC |
| Adam Mendelsohn 2) | 01 Eylül 2022 | · | İlk başvuru | Pasif yatırım | SEC |
| Pixium Vision, S.A. | 08 Ocak 2021 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 28 içeriden öğrenenler · 17 yöneticiler · 12 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Adam Mendelsohn | Chief Executive Officer | 28 Temmuz 2026 A | 3.605.015 | 0 | 0 | $0 |
| Anthony Baldor | Chief Financial Officer | 28 Temmuz 2026 A | · | 0 | 0 | $0 |
| Brigid Makes | Chief Financial Officer | 12 Mayıs 2025 A | 15.000 | 0 | 0 | $0 |
| John T Blake | Chief Financial Officer | 19 Şubat 2020 M | 1.754 | 0 | 0 | $0 |
| Thomas B Miller | Chief Financial Officer | 19 Ocak 2018 A | 78.354 | 0 | 0 | $0 |
| William Patrick Ryan | Chief Operating Officer | 19 Şubat 2020 M | 2.261 | 0 | 0 | $0 |
| Lisa Ellen Porter | Chief Medical Officer | 28 Temmuz 2026 A | · | 0 | 0 | $0 |
| Donald Dwyer | Chief Business Officer | 28 Temmuz 2026 A | 55.000 | 0 | 0 | $0 |
| Truc Le | Chief Operations Officer | 28 Temmuz 2026 A | · | 0 | 0 | $0 |
| Jessy Dana Dorn | VP-Clin & Scientific Affairs | 12 Şubat 2020 A | 1.458 | 0 | 0 | $0 |
| Edward David Randolph | Vice President Manufacturing | 04 Haziran 2019 S | 22 | 0 | 0 | $0 |
| Stephen D Okland | Chief Commercial Officer | 19 Şubat 2019 A | 23.641 | 0 | 0 | $0 |
| David Murray Jacques | VP-Research Development | 04 Ocak 2018 A | · | 0 | 0 | $0 |
| Robert J. Greenberg | Chairman of Board | 04 Ocak 2018 A | 172.911 | 0 | 0 | $0 |
| Gregoire Cosendai | VP Clinical Affairs | 04 Ocak 2018 A | 10.395 | 0 | 0 | $0 |
| John Anthony Moses | Commercial VP Americas | 21 Ocak 2016 A | · | 0 | 0 | $0 |
| Anne-Marie Juliette Ripley | VP of Regulatory Affairs | 04 Aralık 2015 M | 0 | 0 | 0 | $0 |
| Daniel Bradbury | Yönetim kurulu üyesi | 27 Temmuz 2026 A | · | 0 | 0 | $0 |
| Gregg Williams | Yönetim kurulu üyesi | 15 Temmuz 2026 P | 36.912.736 | 18 | 0 | $26.599.995 |
| Alexandra L.P. Larson | Yönetim kurulu üyesi | 24 Haziran 2026 A | 2.166 | 0 | 0 | $0 |
| Aaron Mendelsohn | Yönetim kurulu üyesi | 24 Haziran 2026 A | 188.170 | 1 | 0 | $24.600 |
| August J Moretti | Yönetim kurulu üyesi | 24 Haziran 2026 A | · | 0 | 0 | $0 |
| Wilford Dean Baker | Yönetim kurulu üyesi | 24 Haziran 2025 A | 197.482 | 0 | 0 | $0 |
| Jonathan Will Mcguire | Yönetim kurulu üyesi | 19 Mayıs 2020 D | 20.469 | 0 | 0 | $0 |
| William J Link PHD | Yönetim kurulu üyesi | 04 Haziran 2019 A | 115.186 | 0 | 0 | $0 |
| Matthew J Pfeffer | Yönetim kurulu üyesi | 04 Haziran 2019 A | 118.301 | 0 | 0 | $0 |
| Alfred E Mann | Yönetim kurulu üyesi | 01 Haziran 2015 A | 33.198 | 0 | 0 | $0 |
| Joachim Eberhard Bolck | 10% sahip | 03 Ocak 2023 P | 2.524.229 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 3 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
VANI Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 10 analist
AL
Medyan hedef
$4.00
+225,2%
2 20,0%
Güçlü Al
7 70,0%
Al
1 10,0%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
3 analist · 2026-09-30Ortalama hedef $3.83 +211,7%
← Tüm hedeflerin altında
Mevcut fiyat $1.23
Düşük$3.50
Ortalama$3.83
Yüksek$4.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| VANI | $94M | -2.9 | · | · | -257.8% | · |
| LNSR | · | -4.1 | 9.2% | · | · | · |
| LUNG | $92M | -1.7 | 8.0% | -59.7% | -87.7% | 74.2% |
| MBOT | $134M | -6.9 | · | · | -24.4% | · |
| OM | $67M | -0.7 | 5.1% | -68.3% | -58.0% | 39.1% |
| STEX | $151M | -0.3 | 122.2% | 29068.8% | -703.0% | · |
| GUTS | $337M | -1.2 | -22.5% | · | 3220.3% | · |
| DXR | · | · | · | · | · | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 13, 2026